Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.

Participants needed: 480
Trial details
Phase: Phase 3Age: 1-3Biological sex: AllType: InterventionalSponsor: DBV TechnologiesUpdated: Jun 18, 2026Locations: 91
Eligibility criteria

Aged 1 through 3 years at Visit 1 (screening). [+4]

Peanut allergic subjects presenting a medical history of severe anaphylaxis to p... [+5]

Read more
Status: Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

This is an open label expanded access program for male and female patients 2 years or older, to provide continued desensitization treatment with DBV712 250 mcg.

Trial details
Age: 2-17Biological sex: AllType: Expanded AccessSponsor: DBV TechnologiesUpdated: Jan 15, 2026Locations: 1
Eligibility criteria

Participation is by invitation, limited to individuals completing clinical study... [+2]

Early withdrawal from a DBV712 clinical study. [+3]

Read more